Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.21B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.12B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$742M |
| 4 |
Meta Platforms (Facebook)
META
|
+$598M |
| 5 |
NVIDIA
NVDA
|
+$507M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$799M |
| 2 |
Etsy
ETSY
|
+$246M |
| 3 |
Zoom
ZM
|
+$241M |
| 4 |
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
|
+$151M |
| 5 |
iShares MSCI Brazil ETF
EWZ
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.17% |
| 2 | Technology | 1.87% |
| 3 | Consumer Discretionary | 1.66% |
| 4 | Communication Services | 1.09% |
| 5 | Financials | 1.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11701
CALL
Aurora
AUR
$11.7B
| $90K | ﹤0.01% |
40,500
+20,700
| +105% | +$51.2K |
|
11702
CALL
Consumer Portfolio Services
CPSS
$203M
| $90K | ﹤0.01% |
12,400
-30,100
| -71% | -$346K |
|
11703
CALL
Cyclerion Therapeutics
CYCN
$17.7M
| $90K | ﹤0.01% |
5,225
+100
| +2% | +$1.72K |
|
|
GAN
11704
PUT
DELISTED
GAN Ltd
GAN
| $90K | ﹤0.01% |
40,500
-11,300
| -22% | -$34.3K |
|
|
XRN
11705
PUT
Chiron Real Estate Inc
XRN
$487M
| $90K | ﹤0.01% |
+2,120
| New | +$117K |
|
11706
PUT
Genprex
GNPX
$3.01M
| $90K | ﹤0.01% |
1
-1
| -50% | -$70K |
|
11707
PUT
Navitas Semiconductor
NVTS
$3B
| $90K | ﹤0.01% |
18,500
-26,100
| -59% | -$136K |
|
11708
CALL
OneSpan
OSPN
$610M
| $90K | ﹤0.01% |
+10,500
| New | +$113K |
|
11709
PUT
Puma Biotechnology
PBYI
$468M
| $90K | ﹤0.01% |
38,100
-16,000
| -30% | -$46.7K |
|
11710
Prelude Therapeutics
PRLD
$437M
| $90K | ﹤0.01% |
13,591
-15,837
| -54% | -$107K |
|
11711
CALL
Wave Life Sciences
WVE
$993M
| $90K | ﹤0.01% |
24,900
+9,300
| +60% | +$30.8K |
|
11712
PUT
Broadwind
BWEN
$103M
| $89K | ﹤0.01% |
29,500
+1,400
| +5% | +$3.57K |
|
|
CXH
11713
DELISTED
MFS Investment Grade Municipal Trust
CXH
| $89K | ﹤0.01% |
13,168
-5,717
| -30% | -$43.7K |
|
11714
CALL
Duluth Holdings
DLTH
$140M
| $89K | ﹤0.01% |
12,700
-25,000
| -66% | -$223K |
|
|
HIX
11715
Western Asset High Income Fund II
HIX
$352M
| $89K | ﹤0.01% |
+20,425
| New | +$108K |
|
11716
AEye
LIDR
$53.5M
| $89K | ﹤0.01% |
2,666
-3,796
| -59% | -$212K |
|
11717
CALL
Quince Therapeutics
QNCX
$34.3M
| $89K | ﹤0.01% |
335
+100
| +43% | +$38.1K |
|
|
OMGA
11718
PUT
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $89K | ﹤0.01% |
+16,500
| New | +$83.6K |
|
11719
CALL
BARK
BARK
$98.6M
| $88K | ﹤0.01% |
2,410
-6,640
| -73% | -$245K |
|
|
DHY
11720
Credit Suisse High Yield Credit Fund
DHY
$236M
| $88K | ﹤0.01% |
+49,898
| New | +$96.4K |
|
11721
eGain
EGAN
$203M
| $88K | ﹤0.01% |
+11,999
| New | +$108K |
|
|
ONTF
11722
CALL
DELISTED
ON24
ONTF
| $88K | ﹤0.01% |
+10,000
| New | +$95.8K |
|
11723
Oportun Financial
OPRT
$338M
| $88K | ﹤0.01% |
+20,247
| New | +$144K |
|
11724
Pixelworks
PXLW
$41.9M
| $88K | ﹤0.01% |
4,568
+1,065
| +30% | +$25.4K |
|
11725
CALL
Transportadora de Gas del Sur
TGS
$4.24B
| $88K | ﹤0.01% |
+11,900
| New | +$75.1K |
|
Similar funds
Jeff Yass's Q3 2022 Portfolio in Review
As of Q3 2022, Jeff Yass held 14,936 positions worth $387B, down 4.3% from $404B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass's Q3 2022 filing shows 2,168 new, 5,454 increased, 5,272 reduced and 1,852 closed positions. Its largest new stake was Vanguard Short-Term Corporate Bond ETF: 714,572 shares worth $53.1M. The largest sale was Tesla, an estimated $799M.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 92% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2022 buy was Vanguard Short-Term Corporate Bond ETF: 714,572 shares worth $53.1M.
- Jeff Yass added most to Amazon in Q3 2022, an estimated $1.21B increase.
- Jeff Yass's biggest Q3 2022 reduction was Tesla, cutting an estimated $799M.
- Jeff Yass fully exited Pershing Square Tontine Holdings, Ltd. in Q3 2022, selling an estimated $151M.
- Jeff Yass's ten largest holdings make up 32% of its $387B portfolio in Q3 2022.
- Jeff Yass opened 2,168 new positions and closed 1,852 in Q3 2022.
- Jeff Yass's portfolio value fell 4.3% quarter-over-quarter to $387B.
Based on Susquehanna International Group's 13F filing for Q3 2022, filed 14 Nov 2022.